Hims & Hers (HIMS) Director David B. Wells Receives RSU Award

What Happened

• David B. Wells, a director of Hims & Hers Health, Inc. (HIMS), received two RSU awards on 2026-08-12 totaling 9,001 restricted stock units (8,223 RSUs and 778 RSUs). The Form 4 reports $0.00 per share (award); the grant price used to calculate value is $30.40, implying an approximate aggregate grant value of $273,630. These are awards (not purchases or sales) and represent a contingent right to receive one share of Class A common stock per RSU if vesting conditions are met.

Key Details

• Transaction date: 2026-08-12; Form 4 filed: 2026-08-14 (timely filing).
• Reported entries: 8,223 RSUs (Derivative, A) and 778 RSUs (Derivative, A); Form shows $0.00 per share (award).
• Grant price / valuation reference: $30.40 per share (used in footnote), total ~ $273,630 for 9,001 RSUs.
• Vesting: F1/F2 — RSUs represent a contingent right to one share each; they vest in full on the first quarterly vesting date after the earlier of the next annual stockholder meeting or the first anniversary of grant (subject to continuous service). F3 — the 778 RSUs were issued in lieu of the Q2 2026 director retainer and will vest in full on the Company’s next quarterly vesting date.
• Shares owned after transaction: not disclosed on the provided filing.
• Transaction code: A = Award/Grant (derivative), not an open‑market purchase or sale.

Context

• RSU grants to directors are common compensation practice and differ from outright purchases; they only convert to actual shares if and when vesting conditions are met. Such awards are routine compensation rather than a direct bullish or bearish trading signal.